EFFECT OF AMPICILLIN VERSUS CEFUROXIME ON THE EMERGENCE OF BETA-LACTAM RESISTANCE IN FECAL ENTEROBACTER-CLOACAE ISOLATES FROM NEONATES

被引:22
作者
BURMAN, LG
BERGLUND, B
HUOVINEN, P
TULLUS, K
机构
[1] NATL PUBL HLTH INST,DEPT MED MICROBIOL,ANTIBIOT RES UNIT,SF-20520 TURKU,FINLAND
[2] ST GORANS CHILDRENS HOSP,DEPT PAEDIAT,S-11281 STOCKHOLM,SWEDEN
关键词
D O I
10.1093/jac/31.1.111
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Enterobacter cloacae strains dominated the aerobic faecal flora of 8·3% of 953 infants discharged from 32 Swedish neonatal intensive care units and the susceptibility of these strains to seven β-lactam antibiotics was determined. Isolates from infants treated with cefuroxime showed slightly increased MICs only to ampicillin, cephalexin and cephalothin as compared to isolates from untreated infants matched for ward and time of sampling (P=0·02). In contrast, E. cloacae isolates from ampicillin treated infants showed markedly elevated MICs of all agents tested including piperacillin, cefuroxime, cefotaxime and ceftazidirne as compared to those from control neonates (P values between 0·001 for ampicillin and 0·017 for cefo taxime). Thus, E. cloacae with cefotaxime MICs as high as 512 mg/L were isolated only after ampicillin therapy. The resistant strains were negative in a colony DNA hybridization assay using gene probes for the plasmid β-lactamases TEM-1, OXA-1 and SHY-1. The resistant strains also showed only one β-lactamase band when crude cell sonicates were analysed by isoelectric focusing, and were not found in other infants in the same ward. The results indicate that the selection of chromo somal E. cloacae mutants, presumably with stably derepressed β-lactamase produc tion, in the faecal flora of neonates is rare during treatment with cefuroxime and more common during ampicillin therapy. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 23 条
[1]   GENTAMICIN VS CEFOTAXIME FOR THERAPY OF NEONATAL SEPSIS - RELATIONSHIP TO DRUG-RESISTANCE [J].
BRYAN, CS ;
JOHN, JF ;
PAI, MS ;
AUSTIN, TL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (11) :1086-1089
[2]  
GALLAGHER PG, 1990, REV INFECT DIS, V12, P8085
[3]   DETECTION OF PLASMID-MEDIATED BETA-LACTAMASES WITH DNA PROBES [J].
HUOVINEN, S ;
HUOVINEN, P ;
JACOBY, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :175-179
[4]  
JOHN JF, 1982, REV INFECT DIS, V4, P13
[5]  
KUHN I, 1991, IN PRESS J MICROBIOL
[6]   ANTIBIOTIC SUSCEPTIBILITY AND BETA-LACTAMASE PRODUCTION IN CLINICAL ISOLATES OF ENTEROBACTER SPP [J].
LINDH, E ;
DORNBUSCH, K ;
JALAKAS, K ;
FORSGREN, A .
APMIS, 1990, 98 (05) :462-470
[8]   CONSENSUS REPORT - ANTIMICROBIAL THERAPY FOR BACTERIAL-MENINGITIS IN INFANTS AND CHILDREN [J].
MCCRACKEN, GH ;
NELSON, JD ;
KAPLAN, SL ;
OVERTURF, GD ;
RODRIGUEZ, WJ ;
STEELE, RW .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (06) :501-505
[9]   HOW PREDICTABLE IS DEVELOPMENT OF RESISTANCE AFTER BETA-LACTAM THERAPY IN ENTEROBACTER-CLOACAE INFECTION [J].
MICHEAHAMZEHPOUR, M ;
PECHERE, JC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (03) :387-395
[10]   OUTBREAK OF CEPHALOSPORIN RESISTANT ENTEROBACTER-CLOACAE INFECTION IN A NEONATAL INTENSIVE-CARE UNIT [J].
MODI, N ;
DAMJANOVIC, V ;
COOKE, RWI .
ARCHIVES OF DISEASE IN CHILDHOOD, 1987, 62 (02) :148-151